Drugs / GED-0507-34-Levo
last change Jul 2017 re-read 3 minutes ago

GED-0507-34-Levo

also known as GED0507
Developed for
ulcerative colitis
Investigated by
PPM Services S.A.

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02808390 Nov 2016 → Jul 2017 ulcerative colitis PPM Services S.A. Terminated No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GED-0507-34-Levo ClinicalTrials.gov intervention name — accepted as the source's own label NCT02808390 ↗
Known as GED0507 “A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active...” NCT02808390 ↗